Boston Scientific | BSX - Net Income


Boston Scientific reported $907M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
AtriCure USD 8.96M 8.85M Jun/2026
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 907M 434M Jun/2026
CONMED USD 23.07M 9.24M Jun/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Danaher USD 870M 159M Jun/2026
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Globus Medical USD 124.3M 16.29M Mar/2026
Illumina USD 207M 73M Jun/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 95M 3.9M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
J&J USD 5.53B 299M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -20.39M 19.8M Mar/2026
Teleflex USD -8.15M 706.18M Mar/2026
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026